查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1599203

全球血管支架市场：按类型、材料、输送方式、产品、最终用户分类 - 预测 2025-2030

Vascular Stent Market by Type (Bare Metal Stent, Bio-Engineered Stent, Drug Eluting Stent), Material (Metallic Stent, Polymer), Mode of Delivery, Product, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血管支架市值为213.4亿美元，预计2024年将达到241.3亿美元，复合年增长率为13.54%，2030年将达519.3亿美元。

血管支架市场包括用于治疗血管狭窄或闭塞的医疗设备的开发和分销。这些支架对于心血管疾病的治疗至关重要，为开放动脉和静脉提供必要的支持，以确保正常的血液流动。由于生活方式的改变和老化，冠状动脉疾病和周边动脉疾病不断增加，血管支架在医疗过程中的应用变得越来越重要。最终用途部分主要包括医院、门诊手术中心、心臟专科中心等，微创手术的进步进一步推动了市场需求。

主要市场统计
基准年[2023] 213.4亿美元
预测年份 [2024] 241.3亿美元
预测年份 [2030] 519.3亿美元
复合年增长率（%） 13.54%

影响该市场的关键成长要素包括支架设计的技术进步，例如药物释放型支架，它可以透过降低血管再阻塞率来改善患者的治疗效果。此外，生物可吸收和完全可降解支架技术的整合代表了未来创新的潜力。与文明病盛行率不断上升、医疗保健支出不断增加以及对血管併发症早期疗育的意识不断增强，进一步推动了市场需求。然而，与先进支架技术相关的限制，例如高成本、监管障碍以及支架血栓症等潜在併发症，对市场成长构成了挑战。

创新机会在于生物分解性支架的开发以及人工智慧的整合以实现个人化治疗计划和改善病患监测。一个重要的研究领域是提高支架的生物相容性和功能性，以满足不同患者的需求。作为一个竞争激烈的市场，保持领先地位和市场相关性需要持续研究，并专注于新材料开发和非侵入性治疗方法。公司应致力于利用策略伙伴关係关係并投资于研发，以提高产品多样化和市场渗透率。解决负担能力问题并确保有利的报销政策对于促进更广泛的采用也至关重要，特别是在医疗基础设施正在发展的新兴市场。

市场动态：揭示快速发展的血管支架市场的关键市场洞察

供需的动态交互作用正在改变血管支架市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 血管疾病盛行率增加和老年人口增加
    • 随着健康保险覆盖范围的扩大，手术变得越来越容易。
    • 对微创医疗程序的需求不断增长
  • 市场限制因素
    • 替代药物的可用性和产品召回
  • 市场机会
    • 生物可吸收支架的开发日益受到关注
    • 增加联合策略倡议以扩大业务
  • 市场挑战
    • 与支架置入相关的併发症

波特五力：驾驭血管支架市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血管支架市场的外部影响

外部宏观环境因素对血管支架市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解血管支架市场的竞争格局

血管支架市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵血管支架市场供应商的绩效评估

FPNV定位矩阵是评估血管支架市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了血管支架市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对血管支架市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 血管疾病盛行率增加和老年人口增加
      • 健康保险覆盖范围将扩大，使外科手术变得更加容易。
      • 对微创医疗程序的需求增加
    • 抑制因素
      • 替代医学的可用性和产品召回
    • 机会
      • 生物可吸收支架的发展越来越受到人们的关注。
      • 加强业务扩展的联合策略倡议
    • 任务
      • 与支架置入相关的併发症
  • 市场区隔分析
    • 最终用户：在门诊手术中心采用血管支架以获得高品质护理和快速康復
    • 产品：利用髂支架预防跛行、肢体缺血等併发症
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章血管支架市场：依类型

  • 裸金属支架
  • 生物工程支架
  • 药物释放型支架
  • 双治疗支架

第七章血管支架市场：依材料分类

  • 金属支架
  • 聚合物

第八章以输送方式分類的血管支架市场

  • 球囊扩张型支架
  • 自动扩张型支架

第九章血管支架市场：副产品

  • 冠状动脉支架
  • 週边血管支架
    • 腹部主动脉血管瘤
    • 胸主动脉瘤
  • 外周支架
    • 颈动脉支架
    • 股骨支架
    • 髂支架
    • 肾动脉支架

第10章血管支架市场：依最终用户分类

  • 门诊手术中心
  • 心臟中心
  • 医院

第十一章 北美、南美血管支架市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太血管支架市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲血管支架市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 波士顿科学透过收购 Silk Road Medical 加强血管产品组合和长期成长
    • Abbott 推出 Xience Sierra 冠状动脉支架系统，以加强对心臟病患者的护理
    • SMT 与 HeartX 之间的策略合作彻底改变了全球先天性心臟疾病的治疗
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical, Inc
  • CryoLife, Inc.
  • Elixir Medical Corporation
  • Endologix, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt. Ltd
  • Microport Scientific Corporation
  • Purple Medical Solution Pvt. Ltd
  • Sahajanand Medical Technologies Pvt. Ltd
  • Stryker Corporation
  • Terumo Corporation
  • Veryan Medical Limited.
  • WL Gore & Associates, Inc.
Product Code: MRR-034B5003037F

The Vascular Stent Market was valued at USD 21.34 billion in 2023, expected to reach USD 24.13 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 51.93 billion by 2030.

The vascular stent market encompasses the development and distribution of medical devices used to treat narrowed or blocked blood vessels. These stents are critical in managing cardiovascular diseases, offering essential support to open arteries and veins, thus ensuring proper blood flow. With increasing instances of coronary artery disease and peripheral artery disease, driven by lifestyle changes and growing aging populations, the application of vascular stents in medical procedures becomes crucial. End-use sectors primarily include hospitals, ambulatory surgical centers, and specialized cardiac centers, with a significant impetus from advancements in minimally invasive procedures further driving market demand.

KEY MARKET STATISTICS
Base Year [2023] USD 21.34 billion
Estimated Year [2024] USD 24.13 billion
Forecast Year [2030] USD 51.93 billion
CAGR (%) 13.54%

Key growth factors influencing this market include technological advancements in stent design, such as drug-eluting stents, which enhance patient outcomes by reducing restenosis rates. Additionally, the integration of bioresorbable and fully degradable stent technologies showcases potential opportunities for future innovation. The increasing prevalence of lifestyle disorders, coupled with rising healthcare expenditures and awareness regarding early intervention in vascular complications, further propels market demand. However, limitations such as high costs associated with advanced stent technologies, regulatory hurdles, and potential complications such as stent thrombosis present challenges to market growth.

Innovation opportunities lie in developing biodegradable stents and integrating artificial intelligence for personalized treatment planning and improved patient monitoring. A key area for research is enhancing the biocompatibility and functionality of stents to cater to diverse patient needs. The competitive nature of the market necessitates continuous research, focusing on new material development and non-invasive treatment methods to maintain leadership and market relevance. Companies should aim to leverage strategic partnerships and investments in R&D for product diversification and to enhance market penetration. Addressing affordability and securing favorable reimbursement policies will also be vital to fostering broader adoption, especially in emerging markets with growing healthcare infrastructures.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Stent Market

The Vascular Stent Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of vascular diseases and growth in geriatric population
    • Expanding health insurance coverage makes surgical procedures more accessible,
    • Rising demand for minimally invasive medical procedures
  • Market Restraints
    • Availability of alternative medical treatments and product recalls
  • Market Opportunities
    • Rising focus on bioresorbable stents developments
    • Increasing collaborative strategic initiatives for business expansion
  • Market Challenges
    • Complications associated with the stent implementation

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Stent Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Stent Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Stent Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Stent Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Stent Market

A detailed market share analysis in the Vascular Stent Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Stent Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Stent Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Stent Market

A strategic analysis of the Vascular Stent Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Inc, CryoLife, Inc., Elixir Medical Corporation, Endologix, Inc., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Stryker Corporation, Terumo Corporation, Veryan Medical Limited., and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Vascular Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Bare Metal Stent, Bio-Engineered Stent, Drug Eluting Stent, and Dual Therapy Stent.
  • Based on Material, market is studied across Metallic Stent and Polymer.
  • Based on Mode of Delivery, market is studied across Balloon-Expandable Stent and Self-Expanding Stent.
  • Based on Product, market is studied across Coronary Stent, Evar Stent Graft, and Peripheral Stent. The Evar Stent Graft is further studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm. The Peripheral Stent is further studied across Carotid Stent, Femoral Stent, Iliac Stent, and Renal Artery Stent.
  • Based on End-User, market is studied across Ambulatory Surgical Center, Cardiac Center, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of vascular diseases and growth in geriatric population
      • 5.1.1.2. Expanding health insurance coverage makes surgical procedures more accessible,
      • 5.1.1.3. Rising demand for minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative medical treatments and product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising focus on bioresorbable stents developments
      • 5.1.3.2. Increasing collaborative strategic initiatives for business expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with the stent implementation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. End-Users: Adoption of vascular stent in ambulatory surgical centers for high-quality care and rapid recovery
    • 5.2.2. Product: Utilisation of iliac stents for prevention of complications such as claudication and limb ischemia
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Stent Market, by Type

  • 6.1. Introduction
  • 6.2. Bare Metal Stent
  • 6.3. Bio-Engineered Stent
  • 6.4. Drug Eluting Stent
  • 6.5. Dual Therapy Stent

7. Vascular Stent Market, by Material

  • 7.1. Introduction
  • 7.2. Metallic Stent
  • 7.3. Polymer

8. Vascular Stent Market, by Mode of Delivery

  • 8.1. Introduction
  • 8.2. Balloon-Expandable Stent
  • 8.3. Self-Expanding Stent

9. Vascular Stent Market, by Product

  • 9.1. Introduction
  • 9.2. Coronary Stent
  • 9.3. Evar Stent Graft
    • 9.3.1. Abdominal Aortic Aneurysm
    • 9.3.2. Thoracic Aortic Aneurysm
  • 9.4. Peripheral Stent
    • 9.4.1. Carotid Stent
    • 9.4.2. Femoral Stent
    • 9.4.3. Iliac Stent
    • 9.4.4. Renal Artery Stent

10. Vascular Stent Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Center
  • 10.3. Cardiac Center
  • 10.4. Hospital

11. Americas Vascular Stent Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Vascular Stent Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Vascular Stent Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Boston Scientific to boost vascular portfolio and long-term growth with Silk Road Medical acquisition
    • 14.3.2. Abbott introduces Xience Sierra coronary stent system for enhanced heart patient care
    • 14.3.3. Strategic partnership between SMT and HeartX to revolutionize congenital heart defect treatment worldwide
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. B. Braun Melsungen AG
  • 3. Becton, Dickinson and Company
  • 4. Biosensors International Group, Ltd.
  • 5. Biotronik SE & Co. KG
  • 6. Boston Scientific Corporation
  • 7. Cook Medical, Inc
  • 8. CryoLife, Inc.
  • 9. Elixir Medical Corporation
  • 10. Endologix, Inc.
  • 11. Medtronic PLC
  • 12. Meril Life Sciences Pvt. Ltd
  • 13. Microport Scientific Corporation
  • 14. Purple Medical Solution Pvt. Ltd
  • 15. Sahajanand Medical Technologies Pvt. Ltd
  • 16. Stryker Corporation
  • 17. Terumo Corporation
  • 18. Veryan Medical Limited.
  • 19. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. VASCULAR STENT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR STENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR STENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR STENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR STENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR STENT MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR STENT MARKET SIZE, BY BARE METAL STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR STENT MARKET SIZE, BY BIO-ENGINEERED STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR STENT MARKET SIZE, BY DRUG ELUTING STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR STENT MARKET SIZE, BY DUAL THERAPY STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR STENT MARKET SIZE, BY METALLIC STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR STENT MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR STENT MARKET SIZE, BY BALLOON-EXPANDABLE STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR STENT MARKET SIZE, BY SELF-EXPANDING STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR STENT MARKET SIZE, BY CORONARY STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR STENT MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR STENT MARKET SIZE, BY CAROTID STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR STENT MARKET SIZE, BY FEMORAL STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR STENT MARKET SIZE, BY ILIAC STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR STENT MARKET SIZE, BY RENAL ARTERY STENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VASCULAR STENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY EVAR STENT GRAFT, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY PERIPHERAL STENT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM VASCULAR STENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 325. VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 326. VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2023